Lipocine Inc. ( LPCN) - Key Metrics
LPCN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.02 | -$0.32 | -$0.37 | -$0.37 |
| 2026Q1 | $0.02 | -$0.54 | -$0.33 | -$0.33 |
| 2025Q4 | $0.21 | -$0.43 | -$0.54 | -$0.54 |
| 2025Q3 | $0.02 | -$0.59 | -$0.55 | -$0.55 |
| 2025Q2 | $0.12 | -$0.41 | -$0.35 | -$0.35 |
LPCN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2 |
| 2026Q1 | 0% | -3.70 |
| 2025Q4 | 0% | -4.78 |
| 2025Q3 | 0% | -1.21 |
| 2025Q2 | 0% | -1.93 |
LPCN
Price: $2.04
52 week price:
Earnings Per Share: -1.85 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 27881
Ebitda: -4.8 millionMarket Capitalization: 17.6 million